64. EORTC-1203: Integration of trastuzumab, with or without pertuzumab, into perioperative chemotherapy of HER-2 positive stomach cancer: INNOVATION EudraCT number 2014-000722-38; NCT02205047

Authors :: Anna Dorothea Wagner
Florian Lordick
J.M. Van Dieren
Christoph Schuhmacher
J.W. van Sandick
Manuel Salto-Tellez
Carmela Caballero
Kozo Kataoka
Heike I. Grabsch
Markus Möhler
Murielle Mauer
N.C.T. van Grieken
Ajlan Atasoy
Rupert Langer
Jae Yong Cho
Yoon-Koo Kang
Arnaud Roth
Source :: European Journal of Surgical Oncology (EJSO). 42:S91-S92
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: 0301 basic medicine
Oncology
medicine.medical_specialty
business.industry
General Medicine
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Trastuzumab
030220 oncology & carcinogenesis
Perioperative chemotherapy
Internal medicine
medicine
Surgery
Pertuzumab
Stomach cancer
business
medicine.drug

Full Text Access

Tools